Bree Foster
Bree Foster is a science writer at Drug Discovery News with over 2 years of experience at Technology Networks, Drug Discovery News, and other scientific marketing agencies. She holds a PhD in comparative and functional genomics from the University of Liverpool and enjoys crafting compelling stories for science.
Articles by Bree Foster
| 6 min read
Efforts to move beyond long-term steroid use are accelerating, with growing awareness of steroid toxicity, new tools to guide tapering, and emerging therapies offering safer alternatives.
| 7 min read
Artificial intelligence is prompting a fundamental rethink of clinical trial design and execution, with the potential to reduce patient burden, improve data quality, and accelerate development timelines.
| 4 min read
As demand grows for high-resolution, multiplexed tissue analysis, automation is key to enabling broader access and clinical application.
| 5 min read
Cell-free expression systems are transforming membrane protein research by enabling faster, more reliable access to functional proteins for drug discovery applications.
| 7 min read
Monitoring ctDNA enables earlier detection, real-time assessment of treatment response, and more personalized strategies that improve patient outcomes across a range of tumor types.
| 6 min read
Home-based healthcare is emerging as a scalable, cost-effective solution to rising systemic pressures, offering resilience in the face of economic, geopolitical, and operational uncertainty.
| 6 min read
A fragile and complex global supply chain leaves heparin vulnerable to disruption, prompting urgent calls for diversification, regulatory clarity, and investment in synthetic alternatives.
| 7 min read
Unified data platforms are key to breaking down silos, improving data accessibility, and enabling more efficient, accurate, and predictive workflows across the drug development lifecycle.
| 6 min read
Recent advancements in imaging technologies are transforming spatial proteomics by enhancing data throughput, resolution, and multiplexing capabilities.
| 4 min read
Pharmaceutical companies are investing in supply chain visibility, ethical sourcing, and proactive strategies to build resilience and protect patient access.
| 4 min read
Pharma supply chains are adopting real-time data and automation to manage shortages and build long-term resilience.
| 6 min read
Integrated software and AI are accelerating drug discovery through faster analysis and smarter decisions.
| 5 min read
Advances in microfluidics are enabling more powerful, high throughput applications in single cell and therapeutic discovery.
| 4 min read
A new benchtop system enables real-time live single-cell functional analysis for immune response, antibody discovery, and cell therapy.
| 4 min read
Synthetic DNA is increasingly used for gene therapies due to its fast production and improved scalability compared to traditional plasmid-based methods.
Page 1 of 2 - 18 Total Items
